TABLE II.
Patient demographics
| Variable |
Patient group
|
p Valuea | |
|---|---|---|---|
| Control | Intervention | ||
| Patients (n) | |||
| Enrolled | 54 | 50 | |
| Evaluable | 41 | 38 | |
| Age (years) | 0.909 | ||
| Median | 67 | 68 | |
| Range | 33–90 | 32–92 | |
| Sex (% men) | 61 | 58 | 0.549 |
| Primary cancer site [n (%)] | 0.152 | ||
| Colorectal | 19 (47) | 25 (66) | |
| Pancreatic | 7 (17) | 3 (8) | |
| Stomach | 6 (15) | 1 (3) | |
| Esophagus | 2 (5) | 2 (5) | |
| Liver | 3 (7) | 2 (5) | |
| Other | 4 (10) | 5 (13) | |
| Median time since diagnosis (days) | 61.5 | 45.0 | 0.074 |
| Stage of disease | 0.052 | ||
| I | 7 | 1 | |
| II | 9 | 6 | |
| III | 13 | 17 | |
| IV | 12 | 14 | |
a
Quantitative variables were compared using the Student t-test or analysis of variance. Categorical data were compared using the chi-square test. Results were considered significant at the 5% critical level (2-tailed p < 0.05).